Skip to main content
. 2023 Jun 9;24(12):9937. doi: 10.3390/ijms24129937
IBD Inflammatory bowel disease
CD Crohn’s disease
UC Ulcerative colitis
GI Gastrointestinal tract
DAO Diamine oxidase
HDC L-histidine decarboxylase
FcεRI FcepsilonRI
SP Substance P
IgE Immunoglobulin E
PLC Phospholipase C
PIP2 Phosphatidylinositol 4,5-diphosphate
DAG Diacylglycerol
IP3 Inositol-1,4,5-triphosphate
PKC Protein kinase C
GM-CSF Granulocyte-macrophage colony-stimulating factor
SCF Stem cell factor
HNMT Histamine-N-methyltransferase
SAM S-adenosyl-L-methionine
NMH N-methylhistamine
HIT Histamine intolerance
HRs Histamine receptors
GPCR Protein-coupled receptor
moDCs Monocyte-derived dendritic cells
MAPK Mitogen-activated protein kinase pathway
FoxP3 Tregs forkhead box P3
VH Visceral hypersensitivity
Ox Oxazolone
AOM Azoxymethane
5-ASK 5-Aminosalicylic Acid
IFX Infliximab
MPO Myeloperoxidase
NLR NOD-like receptor
SNP Single nucleotide polymorphism
IECs Intestinal epithelial cells
IELs Intestinal intraepithelial lymphocytes
DCs Dendritic cells
Th T-helper cells
Tregs Regulatory T-cells
NK-cells Natural killer T-cells
IL Interleukin
TNF Tumor necrosis factor
IFN Interferon
TLRs Toll-like receptors
NFAT Nuclear factor of activated T-cells
cAMP Cyclic adenosine monophosphate
CREB Response element binding protein
AP-1 Activator protein 1
DSS Dextran sulfate sodium
PAMPs Pathogen-associated molecular patterns
NF-κB Nuclear factor κB
PKB Protein kinase B
PAR-2 Protease-activated receptor-2
mTOR Mammalian target of rapamycin
APCs Antigen-presenting cells
TNBS 2,4,6-trinitrobenzenesulfonic acid